Old Web
English
Sign In
Acemap
>
Paper
>
MA16.01 Subsequent Systemic Therapy After Lurbinectedin Discontinuation in Patients With Small-cell Lung Cancer
MA16.01 Subsequent Systemic Therapy After Lurbinectedin Discontinuation in Patients With Small-cell Lung Cancer
2021
Vivek Subbiah
Luis Paz-Ares
Benjamin Besse
Khalil Zaman
M. A. Sala
Cristian Fernandez
Mariano Siguero
Carmen Kahatt
J A Lopez-Vilariño
Ali Zeaiter
Jennifer Arrondeau
J-P Delord
M. Martínez
Luciano Wannesson
Antonio Antón
José Manuel Trigo
Keywords:
Lurbinectedin
Systemic therapy
Oncology
Medicine
in patient
Internal medicine
Discontinuation
non small cell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]